Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates
作者: B. M. KnollR. NogY. WuA. Dhand
作者单位: 1Westchester Medical Center
2New York Medical College
刊名: Infection, 2017, Vol.45 (3), pp.335-339
来源数据库: Springer Nature Journal
DOI: 10.1007/s15010-017-1004-5
关键词: Latent tuberculosisIsoniazidRifapentineSolid organ transplantation
原始语种摘要: Isoniazid daily for 9 months is the recommended regimen for latent tuberculosis infection (LTBI) in solid organ transplant (SOT) candidates, but its use is controversial, due to reports of hepatotoxicity and low treatment completion rates. A 12-week course of once weekly directly observed therapy (DOT) with isoniazid plus rifapentine (3HP) is a new LTBI treatment regimen. Tolerability and safety data of 3HP LTBI treatment in SOT candidates are limited.
全文获取路径: Springer Nature  (合作)
影响因子:2.44 (2012)

  • tuberculosis 肺结核
  • rifapentine 利福喷丁
  • isoniazid 异烟肼
  • weekly 每周的
  • latent 潜在的
  • treatment 处理
  • organ 
  • transplant 移植体
  • reports 判例汇编
  • regimen 生活制度